Xeris Pharmaceuticals, Inc. announced today that it has received regulatory approval from the U.S. Food and Drug Administration (FDA) for …

New research from Mayo Clinic finds that more than 2.3 million adult patients in the U.S. are likely being treated too intensively for their …

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company’s BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment …

Xeris Pharmaceuticals, a company developing ready-to-use injectable and infusible drug formulations, announced positive findings from a global phase …

Bioengineers at the University of California, Los Angeles have developed a new type of insulin that could help prevent hypoglycemia in people who use …

People with diabetes who use insulin to control their blood sugar are prone to experience, hypoglycemia a dangerous condition when blood sugar levels …

Older adults with Type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests new research. Those who are …

Xeris Pharmaceuticals, Inc. announced today that its new drug application (NDA) for its ready-to-use, room-temperature stable liquid glucagon rescue …

It’s back to school time for children across the country, and that means it’s time for moms and dads to get their thinking caps on about …

A new Louisiana State University Pennington Biomedical Research Center study reveals that a novel biomarker might give us new answers necessary to …